ࡱ>  )!bjbjBrBr 4  88O|t"$AS|U|U|U|U|U|U|$~ƀU|z z z U|4j|X%X%X%z ^S|X%z S|X%X%?O0RP% FoP$?||0|Pn!nHRnR)0"X% _U|U|,#,|z z z z n : FDA Regulatory Binder and PI Responsibility Requirements The following checklist details the investigator responsibilities outlined in the FDA Code of Federal Regulations 21 CFR 312 (drugs/biologics) and 812 (devices). The purpose of this checklist is to clarify which documents are needed to provide evidence that the investigator has fulfilled his or her responsibilities in conducting a clinical investigation. Use this checklist for setting up the regulatory binder to conduct your study as well as to prepare for an FDA and/or sponsor inspection. The checklist is divided into the following sections: Investigator responsibilities Drug/Device Accountability Record Retention Onsite documents (listed in the middle column) correspond to the regulations written in 21 CFR 312 and 812. Depending on the specific study, additional documents may be needed. The following table is provided for internal tracking.  Principal Investigator: IRB #: Study Title: IND/IDE Holder: Date: INVESTIGATOR RESPONSIBILITIESFDA RegulationsCorresponding On-site DocumentsComments1. Assure IRB review and approval (312.66, 812.110, 812.150(a))IRB documentation:  FORMCHECKBOX  Initial review  FORMCHECKBOX  Continuing review  FORMCHECKBOX  Amendments  FORMCHECKBOX  Adverse event reports  FORMCHECKBOX  Unanticipated events  FORMCHECKBOX  Protocol deviations  FORMCHECKBOX  Protocol violations  FORMCHECKBOX  Current IB/Device Manual  FORMCHECKBOX  Other IRB correspondence2. Maintain adequate and accurate case histories on each subjects participation in the trial (312.62(b), 812.140(a)(3)) FORMCHECKBOX  Informed consent for all subjects  FORMCHECKBOX  Documentation that informed was obtained prior to study procedures  FORMCHECKBOX  Documentation that the subject was given a copy of the signed and dated consent form  FORMCHECKBOX  Subject eligibility documented  FORMCHECKBOX  Source data  FORMCHECKBOX  Progress notes  FORMCHECKBOX  CRFs  FORMCHECKBOX  Concomitant medications recorded  FORMCHECKBOX  Signature/date of staff obtaining dataFDA RegulationsCorresponding On-site DocumentsComments3. Conduct study according to signed investigator statement, protocol, and applicable regulations (312.60, 812.100) FORMCHECKBOX  Report deviations/violations to IRB  FORMCHECKBOX  Promptly report to IRB any on-site adverse events/unanticipated problems according to UCLA requirements  FORMCHECKBOX  Obtain informed consent in accordance with provisions in 21 CFR 50  4. Personally conduct and supervise the investigation (312.60, 812.100) Ensure: Appropriate delegation Adequate training Adequate supervision FORMCHECKBOX  Delegation log  FORMCHECKBOX  Staff training log  FORMCHECKBOX  Routine research team meeting to review trial progress, AEs, protocol changes  FORMCHECKBOX  Routine meetings with study monitor  FORMCHECKBOX Procedures for internal review of data5. Protect the rights, safety, and welfare of study subjects (312.60, 812.100) FORMCHECKBOX  Adhere to protocol  FORMCHECKBOX  Provide reasonable medical care for AEs,  FORMCHECKBOX  Inform subject when medical care is needed for conditions unrelated to research  FORMCHECKBOX  Investigator is available to subjects during conduct of the study  FORMCHECKBOX  Appropriate delegation to CO-Investigator if PI is not available 6. The Investigator is responsible for providing Sponsor reports: Progress reports Safety reports Deviations from investigational plan Final Reports Financial disclosure reports FORMCHECKBOX  The Investigator has provided sponsor with pertinent correspondence (i.e., enrollment numbers, adverse events, financial information and any changes in financial information)  FORMCHECKBOX  N/A, single center studyDRUG/DEVICE ACCOUNTABILITYFDA RegulationsCorresponding On-site DocumentsComments7. The sponsor is responsible for the record of drug/device disposition: Maintain adequate record of receipt and shipment of investigational drug/device - Assure return of all unused investigational drugs/devices from individual investigators participating in trial or authorize alternative disposition of unused product - Maintain written records of any disposition of the drug/deviceDrug/Device Receipt:  FORMCHECKBOX Drug/Device received from Industry Drug/Device accountability log includes:  FORMCHECKBOX  Receipt date  FORMCHECKBOX  Quantity  FORMCHECKBOX  Lot #  FORMCHECKBOX  Return/disposition  FORMCHECKBOX  Method of disposal  FORMCHECKBOX  Drug/device manufactured on-site and dispensed per the UCLA investigational drug pharmacy policy  FDA RegulationsCorresponding On-site DocumentsComments Drug/Device Shipment  FORMCHECKBOX  Single center study no drug/device shipment  FORMCHECKBOX  Drug/device shipped to multiple sites Drug/device accountability log includes:  FORMCHECKBOX  Date  FORMCHECKBOX  Destination  FORMCHECKBOX  Who shipped  FORMCHECKBOX  Quantity  FORMCHECKBOX  Lot #  FORMCHECKBOX  Return/disposition  FORMCHECKBOX  Method of disposal8. The Investigator is required to maintain adequate records of the disposition of the drug/device (312.62, 812.140(a)(2))Drug/device dispensing record including:  FORMCHECKBOX  Research Pharmacy will manage drug  FORMCHECKBOX  Date  FORMCHECKBOX  Lot #  FORMCHECKBOX  Device #  FORMCHECKBOX  Quantity  FORMCHECKBOX  ID# of subject administered or implanted  FORMCHECKBOX  Disposition/record of return  FORMCHECKBOX  ID of person dispensing  FORMCHECKBOX  Return of drug/device, count & reason9. The Investigator is responsible to ensure control of investigational drug/device (312.61, 812.110(c)) Drug/device will be administered only to those subjects enrolled in the clinical study and under investigator or designees supervision FORMCHECKBOX  Enrollment log/Randomization log  FORMCHECKBOX  Delegation of Responsibility log RECORDS RETENTIONFDA RegulationsCorresponding On Site DocumentsComments10. Sponsor and Investigator: Retain records for 2 years after marketing or 2 years after investigational use is discontinued and FDA notified FORMCHECKBOX  Records are on file     PAGE  Page PAGE 1 Version 2-4-11 ,89:RZ & ^ v ( * +   ŷťťŷŗŷxʼnʼngVg hhCJOJQJ^JaJ hh~[~CJOJQJ^JaJ hh~[~CJOJQJ^JaJh+e\CJOJQJ^JaJhFfCJOJQJ^JaJ#hFfh~[~6CJOJQJ^JaJhCJOJQJ^JaJh~[~CJOJQJ^JaJh~[~5OJQJ^Jho5OJQJ^JhFf5OJQJ^Jh+e\5OJQJ^J 9:* + a   $(& #$/Ifgd gd~[~ & Fgdgd~[~$a$gd~[~   : ] ^ _ ʹzizZziHzi7 h!vh CJOJQJ^JaJ#hFfhFf5CJOJQJ^JaJhFf5CJOJQJ^JaJ h!vhZ/CJOJQJ^JaJ#hFfhZ/5CJOJQJ^JaJhZ/CJOJQJ^JaJ hhCJOJQJ^JaJhCJOJQJ^JaJ hh~[~CJOJQJ^JaJ hhZ/CJOJQJ^JaJ#hhZ/6CJOJQJ^JaJ#hh~[~6CJOJQJ^JaJ zzzzzzzzz $Ifgd!v gd~[~nkd$$IflxD 6 (064 layt{ ! 9 z ̻|j|XC2 h!vhCCJOJQJ^JaJ)jh!vhCCJOJQJU^JaJ#h?h 5CJOJQJ^JaJ#h!vh~5CJOJQJ^JaJ#h!vh 5CJOJQJ^JaJh< "h?5OJQJ^JhZ/CJOJQJ^JaJ h!vh CJOJQJ^JaJ h!vhZ/CJOJQJ^JaJ#hFfhZ/5CJOJQJ^JaJhFf5CJOJQJ^JaJ#hFfh 5CJOJQJ^JaJ s$ $Ifa$gd< " -DM gd?jkd$$Ifl'&( t0&(644 layt{  0 9 www$ $Ifa$gd?wkd,$$Ifl'&(  t 0&(644 lap yt< "9 : z I<,<$ $Ifa$gd? $Ifgd?kd$$IflF'-   t0&(6    44 lapytIs/   & ' ( > ? M hP/jh!vhMCJOJQJU^JaJ/j+h!vhMCJOJQJU^JaJ/jh!vhMCJOJQJU^JaJ/jCh!vhMCJOJQJU^JaJ h!vh CJOJQJ^JaJ h!vhCCJOJQJ^JaJ)jh!vhCCJOJQJU^JaJ/jh!vhMCJOJQJU^JaJ  > d [akd$$IflF'- t0&(6    44 laytIs/ $Ifgd? M N O d e s t u Z[\jklyhhP/jh!vhMCJOJQJU^JaJ h!vh CJOJQJ^JaJ/joh!vhMCJOJQJU^JaJ/jh!vhMCJOJQJU^JaJ/jh!vhMCJOJQJU^JaJ h!vhCCJOJQJ^JaJ)jh!vhCCJOJQJU^JaJ/jh!vhMCJOJQJU^JaJNO]л᣻raIrara/j}h!vhFfCJOJQJU^JaJ h!vhFfCJOJQJ^JaJ)jh!vhFfCJOJQJU^JaJhCCJOJQJ^JaJh?CJOJQJ^JaJ/jh!vhMCJOJQJU^JaJ)jh!vhCCJOJQJU^JaJ h!vh CJOJQJ^JaJ h!vhCCJOJQJ^JaJhFfCJOJQJ^JaJ[N BC ))$If^)`gd{   $If^ `gd? zz$If^z`gd? $Ifgd? ]^_  AyaI/jA h!vhFfCJOJQJU^JaJ/j h!vhFfCJOJQJU^JaJ/jU h!vhFfCJOJQJU^JaJ/j h!vhFfCJOJQJU^JaJ/ji h!vhFfCJOJQJU^JaJ h!vhFfCJOJQJ^JaJ)jh!vhFfCJOJQJU^JaJ/jh!vhFfCJOJQJU^JaJABD}~()789EȷrZLh{CJOJQJ^JaJ/jQh!vh{CJOJQJU^JaJ/j h!vh{CJOJQJU^JaJ/je h!vh{CJOJQJU^JaJ)jh!vh{CJOJQJU^JaJ h!vh{CJOJQJ^JaJh{#h!vh{5CJOJQJ^JaJ h!vh CJOJQJ^JaJ h!vhCCJOJQJ^JaJCDTt}n^^^$ $Ifa$gdhDkd $$IflF'- t0&(6    44 laytIs/}~(NAA, ))$If^)`gd{ $Ifgd?kde $$IflF'- 0&(6    4 lapytIs/EP: & F $If^gd?kd$$IflF'- t0&(6    44 laytIs/ $Ifgd?$If^`gd{EMdv1g ))$If^)`gd{ )$If^)`gd{ ))$If^)`gd{ & F $Ifgd? $Ifgd? E12@ABghvwxɱəɁiQ/jMh!vh{CJOJQJU^JaJ/jh!vh{CJOJQJU^JaJ/jah!vh{CJOJQJU^JaJ/jh!vh{CJOJQJU^JaJ/juh!vh{CJOJQJU^JaJ h!vh{CJOJQJ^JaJ)jh!vh{CJOJQJU^JaJ h!vh{CJOJQJ^JaJQnaaL7 V$If^V`gd{ ))$If^)`gd{ $Ifgd?kd$$IflF'- t0&(6    44 laytIs/$%&QR`abyaPBh{CJOJQJ^JaJ h!vh{CJOJQJ^JaJ/jIh!vh{CJOJQJU^JaJ/jh!vh{CJOJQJU^JaJ/j]h!vh{CJOJQJU^JaJ/jh!vh{CJOJQJU^JaJ h!vh{CJOJQJ^JaJ)jh!vh{CJOJQJU^JaJ/jqh!vh{CJOJQJU^JaJ[\];kd$$IflF'- t0&(6    44 laytIs/ $Ifgd?V$If^V`gd{ VV$If^V`gd{ $Ifgd? $If^`gd{ & F $Ifgd? & F $Ifgd? !klUVޱޣދއyi\J= *hIs/5OJQJ^J#h!vhIs/5CJOJQJ^JaJ *hhD5OJQJ^J *h6,hhD5OJQJ^JhIs/hIs/5OJQJ^JhhD/jh!vh{CJOJQJU^JaJh{CJOJQJ^JaJ/jmh!vh{CJOJQJU^JaJ)jh!vh{CJOJQJU^JaJ h!vh{CJOJQJ^JaJ h!vh{CJOJQJ^JaJne $IfgdhDkdY$$IflF'- t0&(6    44 laytIs/ $$Ifa$gd?ekd$$Ifly' (0&(64 laythD,LUzzz$ $Ifa$gdIs/tkd$$Ifl' ( @ 0&(64 lap ytIs/UVNA* & F 0$If`0gd!v $Ifgd!vkdT$$IflF'- 0&(6    4 lapytIs/V'(/   _`nop޾ﰛkS/j@h!vhIs/CJOJQJU^JaJ/jh!vhIs/CJOJQJU^JaJ/jTh!vhIs/CJOJQJU^JaJ)jh!vhIs/CJOJQJU^JaJhIs/CJOJQJ^JaJ#hIs/hIs/5CJOJQJ^JaJhIs/CJOJQJ^JaJ h!vhIs/CJOJQJ^JaJ h!vhIs/CJOJQJ^JaJ /X~zzzzzzz $Ifgd!v $If^gdIs/$ $If^a$gdIs/$ $Ifa$gdIs/ & F $If^`gdIs/ & F $If^`gdIs/ L$If^`LgdIs/ &'(y٩ّykgUQh]"#h!vh]"5CJOJQJ^JaJhIs/hIs/CJOJQJ^JaJ/jh!vhIs/CJOJQJU^JaJ/jh!vhIs/CJOJQJU^JaJ/j,h!vhIs/CJOJQJU^JaJ/jh!vhIs/CJOJQJU^JaJ h!vhIs/CJOJQJ^JaJ)jh!vhIs/CJOJQJU^JaJnl\\\$ $Ifa$gd< "kd$$IflF'- t0&(6    44 laytIs/N8 & F 0$If^`0gd!v & F $If^gd!vkd<$$IflF'- 0 (6    4 lapyt]" !/01̷ޟ޷އ޷o޷W޷/jh!vh]"CJOJQJU^JaJ/j(h!vh]"CJOJQJU^JaJ/jh!vh]"CJOJQJU^JaJ/j<h!vh]"CJOJQJU^JaJ)jh!vh]"CJOJQJU^JaJ#h]"h]"5CJOJQJ^JaJ h!vh]"CJOJQJ^JaJ h!vh]"CJOJQJ^JaJ X *V $Ifgd!v YY$If^Y`gd]"$ $Ifa$gd]" !"#12@AB]^lmn()7yaO#h]"h]"5CJOJQJ^JaJ/j!h!vh]"CJOJQJU^JaJ/jv!h!vh]"CJOJQJU^JaJ/j!h!vh]"CJOJQJU^JaJ/j h!vh]"CJOJQJU^JaJ h!vh]"CJOJQJ^JaJ)jh!vh]"CJOJQJU^JaJ/j h!vh]"CJOJQJU^JaJ(]tl_O:__ YY$If^Y`gd]"$ $Ifa$gd]" $Ifgd!vkdb"$$IflR F'- t0 (6    44 layt]"789]^lmntuyaI/jb%h!vh]"CJOJQJU^JaJ/j$h!vh]"CJOJQJU^JaJ/jv$h!vh]"CJOJQJU^JaJ/j$h!vh]"CJOJQJU^JaJ/j#h!vh]"CJOJQJU^JaJ h!vh]"CJOJQJ^JaJ)jh!vh]"CJOJQJU^JaJ/j#h!vh]"CJOJQJU^JaJ,VY$If^Y`gd]"Y$If^Y`gd]" $Ifgd!v  ,-;<=VWefgfgsesM/j'h!vh]"CJOJQJU^JaJh]"CJOJQJ^JaJ h!vh]"CJOJQJ^JaJ/j&h!vh]"CJOJQJU^JaJ/jN&h!vh]"CJOJQJU^JaJ/j%h!vh]"CJOJQJU^JaJ)jh!vh]"CJOJQJU^JaJ h!vh]"CJOJQJ^JaJh]"CJOJQJ^JaJ naJ=aa h$If^hgd]" & F h$If`gd]" $Ifgd!vkd:'$$IflF'- t0 (6    44 layt]" , - 5 6 7 T U n]nL7])jh!vhH8CJOJQJU^JaJ h!vhH8CJOJQJ^JaJ h!vhH8CJOJQJ^JaJ h!vh CJOJQJ^JaJ#hh 5CJOJQJ^JaJ#hh5CJOJQJ^JaJh?5OJQJ^Jh5OJQJ^Jh6,h6,5 h!vh]"CJOJQJ^JaJ)jh!vh]"CJOJQJU^JaJ/j^(h!vh]"CJOJQJU^JaJa_S $$Ifa$gd?kd($$IflF'- t0 (6    44 layt]" $Ifgd!v - 6 zzz$ $Ifa$gdtkd)$$Ifl'&(  0&(64 lap yt]"6 7 U j I<% & F h$If`gd]" $Ifgd!vkd**$$IflF'0$  t0&(6    44 lapyt$|j TKIII gd~[~kd+$$IflF'0$ t0&(6    44 layt$| $Ifgd!v h$If^hgd]" !!!! ! !!!lUBU$h`x?hIs/0JCJOJQJ^JaJ-jh`x?hIs/0JCJOJQJU^JaJ$h`x?h`x?0JCJOJQJ^JaJhIs/ hIs/0JjhIs/0JUhLz jhLz U hZ/h CJOJQJ^JaJ h!vh CJOJQJ^JaJ h!vhH8CJOJQJ^JaJ)jh!vhH8CJOJQJU^JaJ/j#+h!vhHGCJOJQJU^JaJ !!!!&!'!(!)! gd~[~ )$&#$gd`x?h]hgd~ &`#$gd; !!!!%!&!'!(!)! hZ/h CJOJQJ^JaJhLz hIs/ h`x?hIs/CJOJQJ^JaJ h`x?h`x?CJOJQJ^JaJ$h`x?hIs/0JCJOJQJ^JaJ-jh`x?hIs/0JCJOJQJU^JaJ)h_0JCJOJQJ^JaJmHnHu21h:pFf/ =!"#$% $$If!vh5D#vD:V lx 6 (065D/  4yt{$$If!vh5&(#v&(:V l t0&(65&(yt{$$If!vh5&(#v&(:V l  t 0&(65&(p yt< "$$If!vh5-55 #v-#v#v :V l  t0&(65-55 / pytIs/tDeCheck1tDeCheck2tDeCheck3tDeCheck4tDeCheck5tDeCheck6tDeCheck7tDeCheck8tDeCheck9$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/vDeCheck10vDeCheck11vDeCheck12vDeCheck13vDeCheck14vDeCheck15vDeCheck16vDeCheck17vDeCheck18$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/$$If!vh5-55 #v-#v#v :V l 0&(65-55 4pytIs/vDeCheck19vDeCheck20vDeCheck21$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/vDeCheck22vDeCheck23vDeCheck24vDeCheck25vDeCheck26$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/vDeCheck27vDeCheck28vDeCheck29vDeCheck30vDeCheck31$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/vDeCheck32vDeCheck33$$If!vh5-55 #v-#v#v :V l t0&(65-55 ytIs/$$If!vh5 (#v (:V ly0&(65 (/  / 4ythD$$If!vh5 (#v (:V l @ 0&(65 (4p ytIs/$$If!vh5-55#v-#v#v:V l 0&(65-554pytIs/vDeCheck35vDeCheck36vDeCheck37vDeCheck38vDeCheck39vDeCheck40vDeCheck41$$If!vh5-55#v-#v#v:V l t0&(65-55ytIs/$$If!vh5-55#v-#v#v:V l 0 (65-554pyt]"vDeCheck41vDeCheck41vDeCheck41vDeCheck42vDeCheck43vDeCheck44vDeCheck45vDeCheck46vDeCheck47$$If!vh5-55#v-#v#v:V lR t0 (65-55yt]"vDeCheck48vDeCheck49vDeCheck50vDeCheck51vDeCheck52vDeCheck53vDeCheck54vDeCheck55vDeCheck56$$If!vh5-55#v-#v#v:V l t0 (65-55yt]"vDeCheck57vDeCheck58$$If!vh5-55#v-#v#v:V l t0 (65-55yt]"$$If!vh5&(#v&(:V l  0&(65&(4p yt]"$$If!vh5055$ #v0#v#v$ :V l  t0&(65055$ pyt$|vDeCheck59$$If!vh5055$ #v0#v#v$ :V l t0&(65055$ yt$|^ 2 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~_HmH nH sH tH @`@ NormalCJ_HaJmH sH tH DA`D Default Paragraph FontVi@V  Table Normal :V 44 la (k (No List jj Z/ Table Grid7:V04 @4 ~Footer  !.)@. ~ Page Number4"4 `x?Header  H$616 `x? Header CharCJaJPK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] ) 777: M ]AEV7 !)!$&).03579;@B 9 [C}EU6 j )! !"#%'(*+,-/12468:<=>?A'>Ndt[kN^  ( 8 1 A g w  % Q a     _o' 0"1A]m(8]mt ,<Vf)G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G$G G G G G G G G$G$G$G G G G G G G G G G G G G G G G G G #%:!!@  @ 0(  B S  ?H0(  3Check1Check2Check3Check4Check5Check6Check7Check8Check9Check10Check11Check19Check20Check21Check22Check23Check24Check25Check26Check27Check28Check29Check30Check31Check32Check33Check35Check36Check37Check38Check39Check40Check41Check42Check43Check44Check45Check46Check47Check48Check49Check50Check51Check52Check53Check54Check55Check56Check57Check58Check59?e\) 2 h  R  `2^)^u-W*  !"#$%&'()*+,-./012(Oul 9 B x  & b  ! p(#Bn9n=g*b b b $*'*9*urn:schemas-microsoft-com:office:smarttagsplace 0aE '*'* _p(y  #1B]n(9]nt,=Vgfg %* _p(y  #1B]n(9]nt,=Vgfg5 %'*D5! 0~ ޕ%D > #iCiJ5YE #EBJb sNzB]T,yOwVͼVZ쎰 9_erBy"d$a7h(DANs,*@mt^xch^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJQJo(hHh^`OJPJQJ^Jo(hH- pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH^`o(.h^`OJPJQJ^Jo(hH- pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh88^8`OJQJo(hHh^`OJQJ^Jo(hHoh  ^ `OJQJo(hHh  ^ `OJQJo(hHhxx^x`OJQJ^Jo(hHohHH^H`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hH^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.h^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hHh^`OJPJQJ^Jo(hH-h^`OJQJ^Jo(hHohpp^p`OJQJo(hHh@ @ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohPP^P`OJQJo(hH^`o(. ^`hH. pLp^p`LhH. @ @ ^@ `hH. ^`hH. L^`LhH. ^`hH. ^`hH. PLP^P`LhH.B]T 9_a7h@mty"diC%D >5YEVZNs! 0sNyOwVEBJ                                                                                                           g f a,2{5=EHN[Q ?Ngl} +.LT[a(})*046JH8]} 8!.8;tFQJT\0`2`Kgig Ytc1[  !4Q[*mXl _*=ac . : C vG m  b@ D J i r v Lz `} ^  ^ : LH T u  (4 B E [ f n o  I    ' ( ) 8 A 9D kJ N V Md ,l   g4>LlkVmw5| $Z136C?HHJS]a^w{wx;6C\K>MYSmr| h &B06iCJcsJj ,#*>+?aM[`rTxx{a#&/237@AC7UeX cY 8CL T1{0R3= h[h[rww'Da d &E5*^ef.c4!7u9:GAMCGZs3z6{7 +'mFNVX,^Un~x\  i. /8PR[2f}jppt}5,TWoZ*2e3;gZQa/#15'?}EXLN.]^bLjlpz+G,I?@H+Y_VftN|v  %#v:CIbPe[)|~u67/;7EGR`x g_ lj j u~ 2!!.!!G!_J!Q!R!D_!z!"< """ """$3"T"o~"U##=#?###x-#B#qI#I[#7\#l#}#$: $c$$$$~'$.$>$8D$L$fY$\$]$lh$x$% %%%9(%|E%E%EK%!T%_%l%p%"&X&p[&g&Wn&'{'y '+'e4'7'G'M'P'>]'l'2(=(U(Ch(}u(v({(|("))\)G) )!)J)xP)^)[f)-t)[|)*p *d+*A*tO*T*U*Co*;++X'+A+C+I+O+fX+oX++,,,*,\,,eO,T,0d,9e,Ms,-p -->-E-H-J-K-K-5j-j-j- ...".`$.T,.0.94.gB.L.gj.z. /`///T/W/`/c/Is/x/#00( 000(0F40S@0V00a0h0j0w00,1)P12T1W1S]1X`1k1Ap1s1M2%2C82O2|Q2W2\2uf2a3%3B33e=3C3M3@]3g3n3Au3 44%4/474Y4B_4z4M5;5!5)53-575[5f5{5/|5 6656X76@6J6W6 }6?77)7Y87OS7m7o71q7,r7x7 88 8M3888B8)R8g8bi8w8x8A|89999P9S9I\9d9t9`y99[:: :::$(:R5:}>:ZC:Um: ; ;;;z&;Z';)/;QD;F;R;=T;f;<<&<*<I<M<jY<l< p<E=>I#>)>7>_A>_I>Y>Z>-\>h>;?82?6?C?.J?xV?'c?Ik?Dn?w?`x? {?@@i@U@&@?'@u+@U/@9@`@r@hv@ w@z@~|@|@B@BAn%AUAP]A&qAB B$B+B/BMB RB=cBC:CCCi%Ch.C@CBC|\C+mCQuC!~ChD&D@DADaDjD~DE]EE6ERE( F F1FFsF!F6FN9F>FaDFlHF>SFSF!`F kF*&G&>RDRTRrR{RSS/S%@SrBSNSWS]SyS+TNTT|T"T)T0T6TGTX|TUUUD#U40Uk|hklk ~kll%l'l (l?lmXmmm>mJmPmn?n\n;&n-nL.n.n5n7n@nNnG[nbnXnn=n.oI!o#o4oaVo?eopipQFp IpNpQp?dpepqE qqqq:qIqNqQq&WqMcqjqkq5{qq ra ri!r'r.r;rIr1Or+SraVrZrJ_rQ}r#s1s~3s;s0?sjFsLs=QsZbsmsps+tstR t tt]t8t,>tItJtStNUtbYtttt u8uu u 'uN*uMu.RuYulu~u vv),vDvXFvxGvGvqvsv w@wY$w'w:wZwhw|kw}wx#xh5x/9x!Lx OxTxhxxxyyDyy\y4yMyVy[yey}yz?zzUz!z*zSzYXzRYzTvzvz|z {{{'{Y{]{i{y{{{|{| ||| |$|'|0|0|g3|4|9|e:|A|B|+J|zN|Tm| } }J)}S?}N}S}~6~~S~{/~?~G~ I~W~~[~"\~d~}~..1=LDx}Yy*EU*V>akq9%>CGfhiZo*-B IakgqH/[}\`ikPktxS922BoPE Cheum7 &*+6I?;@YgBmvR i5 D$$):LEs[6_{m w Y*-FTCUcy}b$'-/7OYadsl "#*>8IWbc&iw606AQj~*-3]Vm]d_ p:=@M8no6%&+ -d4<IJoPPVVr%*R+,d-@Z\ (+\6svfei!~/;PbRw?d5?pKQQA_ */:lD'rvw,,,2<1UV\0_ y5267;LM9MNy_h!jwp>Zvan! ].-b6 A]IPR[/brDr=X[cgkay-,=-05a7E>SVWXc Mz)Zaget!xg}]!%5.Z3`L|!(2SM:QmWZQ_t}5QdpMx vm!#/9>PP_s$B)w+..0Dzk{}N~ )):CGHL~NYY^x}yt7:|<>KKMSip,AUV"_dhdkt#D*9- 4;gB$HNj3zL\Q V,?S`JA$M026vAB2GI`JbV_gpko{}" P'WZa uvzD *=DJRdK-/d1F^G,ILTiW Z\3f;sLy !!&R*n:P;N\\~i0yJuUXfr7uU~~  j 7B~L$Pye}ggt9GEP^`p /V\.P[(aSl@olwrx m%,-H1EY[Uxyz5`>T\akm*5Qgln/ZX]do|~bD*3K LL dekxuvz | q"6X%(/Nfgmv}P6IW\7_)-]-.3Y47?ODF)kw~eV%CjUl#3+;CTTY[d~! /LQs\ftnz{qWH-AYSTVc(sFuHzw5(i<=HT|]]e*|WrP"95noR&3+BE)GsXetz}*:1:RnU(VVX"Yd0y8T`[],f5TAyIkZ)g%jep_! *F~INQRWSh6 =>DG[nu | >K2![\lqvx7*,h6oOPUb20a;MN*Y_elv"&'(66H<$9+15:;ECFO5gz%Z'm+9//N6;PGMQQYd@dxh5AUWnd{7Y>`\0123"cg$w ~P,u38Q`a2ddmghkwpu~9 "64;iAdLLe%'S.&Tm)6y&(94r<K^kloZGF,1l|%",#'6,qK5P\tixaU#N+/3367M=Mbfpt_~~5 i 'e;LXM]f0gUjPn,ryw.+t14=DiyI ;LbSV\oq|F 37?MOXjxmHoxv,lG$CQXu@}A f&2@CH&^Oh.mO!]fIk1sx|or>.Rs)0568ADoWZ[] 'D4 6819A*DK^` -814ROg!&h*5J8IPWamy+*>-GNPMa%c~dq){ X.8: ACEX_cKi6ko9 w]"Z/6 QYah6lI$0l;BHGK(ajwd 1*99:6<=tXgn-oo{ .3 :@BEW^a:gwkoOun QQVY0[~Yov$%!'y/ 0?*V gqzB)FU[b  053@CF Q\^b_ /3?<R@{o|6 (m*@D K Z\ivxEg.GdHW_khk|Z '. 6#9$CK QW_gr.: #(*-SX]]lmncyzI29C<J SiWcdmLqsc|^ y+ /=>Zs-674;;FQFy&MP@WXgisL|h J (H8*W,]`iwf r*/X02>LSeyIz{G+48:<=Ecp{ <_ke~v}f3-!-oGjMRdQu<&7IDU] [ #+;;?KSrnx{NlKTGVq  $)R3hs  ,f58EfUjx X##\%&Y*6FVZw/7={ZZkbo.tt;=$6NBYl@)@UnknownG*Ax Times New Roman5Symbol3. *Cx Arial?= * Courier New;WingdingsA$BCambria Math"1h ;$[[!r4d??3QHP ?~[~2!xx)FDA Investigator Responsibility ChecklistMalmet, Marciagcalab01H          Oh+'0t  $ 0 < HT\dl,FDA Investigator Responsibility ChecklistMalmet, MarciaNormal gcalab012Microsoft Office Word@@"@^%@^%[՜.+,0 hp  UCLA? *FDA Investigator Responsibility Checklist Title  !"#$%&'()*+,-./0123456789:;<=>?@ABCEFGHIJKLMNOPQRSTUVWXYZ\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F-tData DG,1Table[WordDocument 4SummaryInformation(DocumentSummaryInformation8MsoDataStore -t-tJPW4ZMU50YQFA==2-t-tItem  PropertiesUCompObj yNJNNMRCT0GQYA==2 -t-t    F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q Item  Properties UUORHRQ5LQ==2-t-tItem Properties This value indicates the number of saves or revisions. The application is responsible for updating this value after each revision. DocumentLibraryFormDocumentLibraryFormDocumentLibraryForm